Clinical Trials at Retina Northwest

Retina Northwest is committed to fostering cutting edge treatments for AMD (atrophic and exudative), diabetic eye diseases (macular edema and retinopathy) and vein occlusions (central and branch) through our participation in clinical trials. Brief descriptions of our active clinical trials are listed below.
 
If you are a physician and have questions about any of our trials, or if you would like to refer a patient to our care, please contact our Clinical Research department at 503-274-2121.

Age-Related Macular Degeneration (AMD)

Atrophic ("Dry")
  • OLEi Sponsored by Genentech
    Evaluation of the long-term safety and tolerability of an investigational drug
    for the treatment of geographic atrophy.
    Principal Investigator: Richard F. Dreyer, MD
  • seattle Sponsored by ACUCELA
    Comparing the efficacy and safety of an investigational drug with placebo for
    the treatment of geographic atrophy.
    Principal Investigator: Colin Ma, MD
  • Spectri Sponsored by Roche-Genentech  **Currently Enrolling**
    Evaluation of the long-term safety and tolerability of an investigational drug
    for the treatment of geographic atrophy.
    Principal Investigator: Richard F. Dreyer, MD

Exudative ("Wet")

  • Regeneron Series of Studies Sponsored by Regeneron
    Evaluation of Eylea (aflibercept) as treatment for subretinal neovascularization.
    Principal Investigator: Michael S. Lee, MD
  • Fovista Sponsored by Ophthotech Corp.  **Currently Enrolling**
    Comparing the safety and efficacy of Fovista administered in combination with either
    Avastin (bevacizumab) or Eylea (aflibercept) compared to Avastin (bevacizumab) or Eylea (aflibercept).
    Principal Investigator: Richard F. Dreyer, MD

Diabetic Eye Diseases

Diabetic Macular Edema

  • DRCR Series of Studies Sponsored by NEI / NIH  **Currently Enrolling**
    Treatment for central-involved diabetic macular edema in eyes with very good visual acuity.
    Principal Investigator: Mark A. Peters, MD
  • DRCR Series of Studies Sponsored by NEI / NIH  **Currently Enrolling**
    Short-term evaluation of combination corticosteroid+anti-VEGF treatment for persistent central-involved DME.
    Principal Investigator: Mark A. Peters, MD
  • DRCR Series of Studies Sponsored by NEI / NIH
    Comparing the efficacy and safety of Eylea (aflibercept), Avastin (bevacizumab)
    and Lucentis (ranibizumab) for treatment of diabetic macular edema.
    Principal Investigator: Mark A. Peters, MD
  • REGENERON Series of Studies Sponsored by Regeneron
    Evaluation of Eylea (aflibercept) as treatment for diabetic macular edema.
    Principal Investigator: Michael S. Lee, MD
  • Aerpio Sponsored by Aerpio  **Currently Enrolling**
    Evaluation of AKB-9778 on visual acuity and central retinal thickness in subjects with DME.
    Principal Investigator: Michael S. Lee, MD

Diabetic Retinopathy

  • DRCR Series of Studies Sponsored by NEI / NIH
    Evaluating surgical and medical treatment options for diabetic retinopathy.
    Principal Investigator: Mark A. Peters, MD

Vein Occlusions

  • SCORE II Sponsored by NEI  **Currently Enrolling**
    Comparing Avastin (bevacizumab) every 4 weeks with Eylea (aflibercept) as treatment for central retinal vein occlusion.
    Principal Investigator: Mark A. Peters, MD

Collaborative Studies

  • Fanno Creek Clinic
    Ophthalmic assessments. For more information, please visit their website at
    http://fannocreek.com or call (503) 290-0730.
  • Summit Research Network
    Ophthalmic assessments. For more information, please visit their website at
    http://summitresearchnetwork.com or call (503) 228-CARE (2273).